The effects of macrolides on inflammatory cells

Area of Science:

• Pulmonology
• Pharmacology
• Immunology

Background:

• Chronic airway inflammation involves bronchial epithelial damage and mucus hypersecretion, impairing mucociliary clearance and leading to respiratory infections.
• Neutrophils play a key role in airway inflammation through recruitment, migration, and the release of inflammatory mediators.
• Macrolide antibiotics are known for their antibacterial properties, but emerging evidence suggests non-bactericidal effects.

Purpose of the Study:

• To explore the non-bactericidal properties of macrolide antibiotics.
• To discuss the impact of macrolides on neutrophil function and inflammatory processes in the airways.
• To highlight the potential of macrolides as biological response modifiers in respiratory diseases.

Main Methods:

• Review of existing data on macrolide antibiotic actions.
• Analysis of macrolide effects on neutrophil chemotaxis, cytokine synthesis, adhesion molecule expression, and reactive oxygen species production.
• Examination of macrolide influence on mucus hypersecretion and nitric oxide production.

Main Results:

• Macrolides inhibit inflammatory cell chemotaxis, cytokine synthesis, adhesion molecule expression, and reactive oxygen species production.
• Macrolides can decrease mucus hypersecretion in conditions like diffuse panbronchiolitis, chronic sinusitis, and chronic bronchitis.
• Macrolides accumulate in neutrophils and macrophages at high concentrations, suggesting targeted biological effects.

Conclusions:

• Macrolide antibiotics possess significant non-bactericidal properties that modulate airway inflammation.
• These immunomodulatory effects include reducing neutrophil accumulation and inflammatory mediator release.
• Macrolides represent a promising therapeutic strategy as biological response modifiers for chronic airway inflammatory diseases.